Alnylam Pharmaceuticals
ALNY
#449
Rank
HK$405.02 B
Marketcap
HK$3,066
Share price
-4.55%
Change (1 day)
55.15%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company